1. Chen P, Anderson L, Zhang K, et al. Eosinophilic gastritis/gastroenteritis. Curr Gastroenterol Rep 2021; 23: 13.
2.
Chehade M, Jones S, Pesek R, et al. Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. J Allergy Clin Immunol Pract 2018; 6: 1534‐44.
3.
Ho HE, Chehade M. Development of IgE-mediated immediate hypersensitivity to a previously tolerated food following its avoidance for eosinophilic gastrointestinal diseases. J Allergy Clin Immunol Pract 2018; 6: 649-50.
4.
Barbosa A, Castro F, Meireles P, et al. Eosinophilic esophagitis: latent disease in patients with anaphylactic reaction to cow’s milk. J Allergy Clin Immunol Pract 2018; 6: 451-6.
5.
Wright B, Fernandez-Becker N, Kambham N, et al. Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy. Front Immunol 2018; 9: 2624.
6.
Hill D, Grundmeier R, Ramos M, et al. Eosinophilic esophagitis is a late manifestation of the allergic march. J Allergy Clin Immunol Pract 2018; 6: 1528-33.
7.
Maskey A, Srivastava K, Soffer G, et al. Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens is associated with IL-4/IL-13 and CCL11 but not IgE in genetic susceptible mice. J Inflamm Res 2022; 15: 5527-40.
8.
Kagalwalla A, Wechsler J, Amsden K, et al. Efficacy of a 4-food elimination diet for children with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2017; 15: 1698-707 e7.
9.
Lucendo A, Arias A, Gonzalez-Cervera J, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol 2013; 131: 797-804.
10.
Erwin E, Tripathi A, Ogbogu P, et al. IgE antibody detection and component analysis in patients with eosinophilic esophagitis. J Allergy Clin Immunol Pract 2015; 3: 896-904 e3.
11.
Erwin E, Kruszewski P, Russo J, et al. IgE antibodies and response to cow’s milk elimination diet in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2016; 138: 625-8.
12.
Dellon S, Guo R, McGee S, et al. An allergen-specific immune signature identifies food triggers in eosinophilic esophagitis with high accuracy. Gastroenterology 2018; 154: S260.
13.
Warners M, Terreehorst I, van den Wijngaard RM, et al. Abnormal responses to local esophageal food allergen injections in adult patients with eosinophilic esophagitis. Gastroenterology 2018; 154: 57-60.e2.
14.
Molina-Infante J, Modolell I, Alcedo J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study. J Allergy Clin Immunol 2018; 141: 1365-72.
15.
Letner D, Farris A, Khalili H, et al. Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus 2018; 31: doi: 10.1093/dote/dox122.
16.
Ram G, Lee J, Ott M, et al. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol 2015; 115: 224-8.
17.
Fahey L, Robinson G, Weinberger K, et al. Correlation between aeroallergen levels and new diagnosis of eosinophilic esophagitis in New York City. J Pediatr Gastroenterol Nutr 2017; 64: 22-5.
18.
Larsson H, Bergquist H, Bove M. The incidence of esophageal bolus impaction: Is there a seasonal variation? Otolaryngol Head Neck Surg 2011; 144: 186-90.
19.
Rayapudi M, Mavi P, Zhu X, et al. Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol 2010; 88: 337-46.
20.
Wolf W, Jerath M, Dellon E. De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointest Liver Dis 2013; 22: 205-8.
21.
Jensen E, Kuhl J, Martin L, et al. Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2018; 141: 214-22.
22.
Van Rhijn B, Van Ree R, Versteeg S, et al. Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy Eur J Allergy Clin Immunol 2013; 68: 1475-81.
23.
Jensen E, Kuhl J, Martin L, et al. Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 2018; 141: 632-7.e5.
24.
Capucilli P, Hill D. Allergic comorbidity in eosinophilic esophagitis: mechanistic relevance and clinical implications. Clin Rev Allergy Immunol 2019; 57: 111-27.
25.
Lucendo A, Arias Á, Tenias J. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy, Asthma Immunol 2014; 113: 624-9.
26.
Hill D, Dudley J, Spergel J. The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol Pract 2017; 5: 369-75.
27.
Bene J, Ley D, Roboubi R, et al. Eosinophilic esophagitis after desensitization to dust mites with sublingual immunotherapy. Ann. Allergy Asthma Immunol 2016; 116: 583-4.
28.
Petroni D, Spergel JM. Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy. Ann Allergy Asthma 2018; 120: 237-40.
29.
Capucilli P, Hill D. Allergic comorbidity in eosinophilic esophagitis: mechanistic relevance and clinical implications. Clin Rev Allergy Immunol 2019; 57: 111-27.
30.
Wright B, Fernandez-Becker N, Kambham N, et al. Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy. Front Immunol 2018; 9: 2624.
31.
Goldberg M, Nachshon L, Levy M, et al. Risk factors and treatment outcomes for oral immunotherapy-induced gastrointestinal symptoms and eosinophilic responses (OITIGER). J Allergy Clin Immunol Pract 2020; 8: 125-31.
32.
Jin H, Trogen B, Nowak-Wegrzyn A. Eosinophilic esophagitis as a complication of food oral immunotherapy. Curr Opin Allergy Clin Immunol 2020; 20: 616-23.
33.
Wright B, Fernandez-Becker N, Kambham N, et al. Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy. Clin Gastroenterol Hepatol 2021; 19: 1151-9.e14.
34.
Wasserman R, Hague A, Pence D, et al. Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients. J Allergy Clin Immunol Pract 2019; 7: 418-26.e4.
35.
Goldberg M, Nachshon L, Levy M, et al. Risk factors and treatment outcomes for oral immunotherapy-induced gastrointestinal symptoms and eosinophilic responses (OITIGER). J Allergy Clin Immunol Pract 2020; 8: 125-31.
36.
Straumann A, Lucendo AJ, Miehlke S, et al. Budesonide orodispersible tablets maintain remission in a randomized, placebocontrolled trial of patients with eosinophilic esophagitis. Gastroenterology 2020; 159: 1672-85.
37.
Nhu QM, Moawad F. New developments in the diagnosis and treatment of eosinophilic esophagitis. Curr Treat Options Gastroenterol 2019; 17: 48-62.
38.
Dilollo J, Rodriguez-Lopez E, Wilkey L, et al. Peripheral markers of allergen-specific immune activation predict clinical allergy in eosinophilic esophagitis. Allergy 2021; 76: 3470-8.
